We sold Analabs on strong gains

After years we have identified Analabs as an undervalued stocks.  It has not been active or performing until recently.  Profit wise remained choppy but reviewed it’s assets. 

However we started our selling on this counter a month ago while market at depressed price.  We switched to others that can recover faster.  We managed to hold on half of our holding until recently.  We sold it gradually for CIMB.  At RM 2.50 above already hit our target.  Without new corporate development or better result. We will exit the counter if price moving upward further.